arrow
J

Jan W. Schoones

leiden university medical center
H指数:51
被引数:8,325

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes

EORTC QLQ-C30总结评分在癌症研究中的应用及其与EORTC QLQ-C30总体健康/生活质量量表性能的比较:一项效应量的系统评价和比较分析

2025-10-260
OAAI
B THE USE OF EORTC QLQ-C30 SUMMARY SCORE IN CANCER CLINICAL TRIALS AND ITS PERFORMANCE AS COMPARED WITH THE GLOBAL HEALTH / QUALITY OF LIFE SCALE: A COMPARATIVE ANALYSIS OF EFFECT SIZES

B 癌症临床试验中EORTC QLQ-C30总结评分的应用及其与全球健康/生活质量量表性能的比较:效应量比较分析

2025-10-010
OA
Similar Alterations of the Stratum Corneum Ceramide Profile in Atopic Dermatitis, Psoriasis, and Ichthyosis: Results from a Systematic Review and Meta-Analysis

特应性皮炎、银屑病和鱼鳞病患者角质层神经酰胺谱的相似改变: 一项系统回顾和荟萃分析的结果

2024-10-011
OAAI
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
2024-05-1414
OAAI
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO (vol 50, 107292, 2024)]

由EUSOMA,EUSOBI,ESP (BWG) 和ESSO共同制定的具有不确定的恶性潜能的乳腺病变 (B3病变) 的诊断,治疗和随访的欧洲指南 (vol 50,107292,2024)]

EJSO
IF2.9
2024-03-010
OAAI